A carregar...
The BET-bromodomain inhibitor JQ1 mitigates vemurafenib drug resistance in melanoma
Inhibition of BRAF improves therapeutic efficacy of BRAF-mutant melanoma. However, drug resistance to BRAF inhibitor is inevitable, and the drug resistance mechanisms still remain to be elucidated. Here, BRAF(V600E) mutant cells A375 and SK-MEL-28 were chosen and treated with BRAF inhibitor vemurafe...
Na minha lista:
| Publicado no: | Melanoma Res |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams & Wilkins
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6221393/ https://ncbi.nlm.nih.gov/pubmed/30192303 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CMR.0000000000000497 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|